Résumé Introduction Depuis 30 ans sont commercialisés en France le zolpidem et la
zopiclone, deux hypnotiques apparentés aux benzodiazépines. Les nombreux cas de …

Purpose To determine changes in the prevalence of zolpidem consumption since the
change in the regulations of prescription. Formulations containing zolpidem were subject to …

Purpose Zolpidem and zopiclone are two widely used non-benzodiazepine hypnotics
whose usage seems to be associated to pharmacodependence. However, to our …

Aims In recent years, zolpidem has been the subject of numerous reports of misuse, abuse
and dependence. In view of these risks, the French drug agency (ANSM) decreed in April …

We evaluated the impact of the implementation of a requirement that zolpidem prescriptions
be obtained via secured forms (April 2017) on zolpidem and other hypnotics use in France …

Background: The French national drug regulatory authority stated, in 2017, that a secured
prescription pad must be used for zolpidem prescriptions. This study aimed to evaluate the …

Background In recent years, zolpidem has been the subject of numerous reports of misuse,
abuse and dependence. In view of these risks, the French drug agency decreed the …

Background Case reports indicate dose increase, abuse, and dependence concerning
zolpidem and zopiclone (so-called Z-drugs). Methods We conducted a cross-sectional study …

Objective Aim of this study was to analyse the amount of so-called private prescriptons of
zolpidem and zopiclone (Z drugs) over a 15-year period in Germany. Any doctor can …

Purpose Although evidence is lacking, there is general perception that zolpidem and
zopiclone ('Z‐drugs') are more effective and safer than benzodiazepines leading to an …